Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 41CNS 10Gynecologic 9Gastrointestinal 7Tumor-Agnostic 6Genitourinary 6Thoracic 5Head & Neck 5Sarcoma 4Other solid neoplasm 2Lymphoid 2Endocrine 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1NET 1Dermatologic 1

Conditions

Lymphoma, Non-Hodgkin 2Neoplasms 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1

Interventions

Rituximab 689Cyclophosphamide 614Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 228Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 175Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106Tacrolimus 105obinutuzumab 104Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × abemaciclib × Lymphoid × Clear all
NCT02693535 2026-05-15

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting
4,200 enrolled
LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

NCT01739309 2023-09-21

Study of LY2835219 for Mantle Cell Lymphoma

Eli Lilly and Company

Phase 2 Completed
28 enrolled 20 charts
Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡